GHK-Cu vs MOTS-c
Both compounds are bioactive peptides with broad research profiles, but the published mechanistic work examines different molecular targets in different model systems. GHK-Cu has been investigated for copper-mediated skin remodeling and antioxidant chemistry. MOTS-c has been investigated for AMPK-pathway activation and metabolic homeostasis. This page summarises the published distinctions.
Side-by-side comparison
| Property | Compound A | Compound B |
|---|---|---|
| Structural class | Tripeptide-copper(II) complex (Gly-His-Lys-Cu2+) | 16-residue peptide encoded within the mitochondrial 12S rRNA gene |
| Best-studied mechanism | Copper-mediated antioxidant chemistry; MMP/collagen expression in dermal fibroblasts | AMPK pathway activation; nuclear translocation; metabolic-stress transcriptome regulation |
| Primary research domain | Skin remodeling, hair follicle, wound-bed ECM, oxidative-stress chemistry | Metabolic homeostasis, insulin resistance, exercise physiology, age-related decline |
| Origin | Endogenous tripeptide; present in human plasma | Endogenous mitochondrial-derived peptide |
| Common research routes | Topical, subcutaneous | Subcutaneous, intraperitoneal |
| Ronin catalog vial size | 50 mg lyophilised | 10 mg lyophilised |
How they differ in mechanism
GHK-Cu operates through copper-bound-tripeptide chemistry. The Gly-His-Lys peptide binds Cu2+ with high affinity, and the published literature reports antioxidant activity (reactive-carbonyl quenching), integrin and p63 expression modulation in keratinocytes, MMP and collagen expression changes in dermal fibroblasts, and gene-expression effects relevant to skin regeneration and wound healing.
MOTS-c activates the AMPK pathway and translocates to the nucleus under metabolic stress. The published work describes regulation of the nuclear transcriptome with functional endpoints including metabolic homeostasis, improved insulin sensitivity, enhanced exercise capacity, and neuropathic-pain modulation. The mitochondrial origin places it within the broader mitochondrial-derived-peptide signalling field.
The mechanistic profiles are unrelated. GHK-Cu is a copper-chemistry and matrix-remodeling compound studied in skin and connective tissue. MOTS-c is a metabolic-signalling compound studied through AMPK-mediated pathways. Both peptides are endogenous, but their biological roles as characterised in the published literature are distinct.
How research has examined each
The GHK-Cu literature spans work by Pickart and colleagues since the 1980s, covering oxidative-stress chemistry, keratinocyte biology, dermal-fibroblast dynamics, hair-follicle research, and gene-expression profiling. Recent work has extended to lung fibrosis and zebrafish inflammation models.
The MOTS-c literature has expanded since the 2015 characterisation, covering metabolic homeostasis, gestational diabetes, exercise physiology, cardiovascular endpoints, neuropathic pain, and radiation protection. The peptide’s mitochondrial origin has attracted interest from mitochondrial biologists.
The two literatures do not share primary citations, model systems, or research communities. Both are endogenous peptides studied for broad biological activity, but the tissues and pathways are distinct.
Stacking considerations in research contexts
Combined administration is not described in published research. The mechanisms do not overlap. GHK-Cu ships at 50 mg and MOTS-c at 10 mg in the Ronin catalog, both as lyophilised vials.
Sourcing both at Ronin
Both compounds ship as lyophilised material in glass vials with certificate-of-analysis documentation. The GHK-Cu vial page ships at 50 mg. The MOTS-c vial page ships at 10 mg. Both are research-grade reagents.
Frequently asked research questions
Are GHK-Cu and MOTS-c related?
No. GHK-Cu is a copper-bound tripeptide for skin/matrix research. MOTS-c is a mitochondrial peptide for metabolic-homeostasis research. Unrelated mechanisms.
Both are endogenous — do they share a biological role?
Both are found naturally in human biology, but their characterised roles differ. GHK-Cu is studied in skin and connective-tissue contexts. MOTS-c is studied in metabolic-signalling contexts.
Are they co-administered?
Not in published research.
Do they share storage practice?
Yes. Both are lyophilised and stored at 2-8 degrees Celsius.
Are either approved?
Neither is FDA or Health Canada approved. Both are research-grade reagents.
References
- Pickart L. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science Polymer Edition, 2008. [PMID 18644225]
- Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis. Cell Metabolism, 2015. [PMID 25738459]
- Pickart L et al. Regenerative and Protective Actions of the GHK-Cu Peptide. International Journal of Molecular Sciences, 2018. [PMID 29986520]
- Kim KH et al. MOTS-c translocates to the nucleus to regulate nuclear gene expression. Cell Metabolism, 2018. [PMID 29983246]
- Wan W et al. MOTS-c: effects and mechanisms related to stress, metabolism and aging. Journal of Translational Medicine, 2023. [PMID 36670507]
Comparison pages describe research-context use of the compared compounds. They do not constitute medical, veterinary, or clinical advice. Every compound in the Ronin catalog is sold strictly for laboratory and research use only.